Asymptomatic carriers of clostridium difficile in serbian population

被引:5
作者
Stojanovic, Predrag [1 ,2 ]
Stojanovic, Nevena [3 ]
Kocic, Branislava [1 ,2 ]
Stankovic-Dordevic, Dobrila [1 ,2 ]
Babic, Tatjana [2 ]
Stojanovic, Kristina [4 ]
机构
[1] Fac Med, Dept Microbiol, Nish 18000, Serbia
[2] Inst Publ Hlth Nis, Ctr Microbiol, Nish 18000, Serbia
[3] Gynecol Obstet Clin, Dept Neonatol, Nish 18000, Serbia
[4] Clin Centar, Nish 18000, Serbia
来源
CENTRAL EUROPEAN JOURNAL OF MEDICINE | 2012年 / 7卷 / 06期
关键词
Clostridium difficile; Asymptomatic intestinal carriers; Children; Hospitalized patients; Medical staff; TERM-CARE FACILITIES; NOSOCOMIAL ACQUISITION; RISK-FACTORS; COLONIZATION; PREVALENCE; RESIDENTS; DIARRHEA; INFANTS; TRANSMISSION; INFECTION;
D O I
10.2478/s11536-012-0067-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the research was to determine the intestinal carriers of C. difficile in different human population groups in Serbia. The research enrolled 877 persons with formed stools: (newborn children in maternity hospitals for up to two weeks old) (23), group A; children aged from two weeks to two years (121), group B; children aged two to 10 years (54), group C, healthy individuals aged 10 and over (516), group D; patients hospitalized for at least 48 hours (100), group E; staff of the Clinical Center in Nis, Serbia, (63), group F. The toxins A and B of C. difficile were detected by ELISA-ridascreen Clostridium difficile Toxin A/B (R - Biopharm AG, Darmstadt, Germany). The toxin A of C. difficile was detected using ColorPAC Toxin A test (BectonDickinson, New Jersey, USA). Out of the total number of persons (877), the carriers of certain types of toxin-producing strains of C. difficile were distributed as: 6.04% (A-/B-), 1.83% (A+/B+) and 0.11% (A-/B+). In most groups (5/6), the dominance of non-toxigenic (A-/B-) isolates was established, with the rate of carriers 1.75 - 30.43% depending on the group. Toxigenic isolates were prevalent only in the group F in relation to non - toxigenic (7.94% versus 4.76% of persons). In other groups, the carriers of toxigenic strains ranged from 0.00 - 17.45%. The presence of asymptomatic intestinal carriers of C. difficile in the human population, indicate the possible reservoirs and sources of infection.
引用
收藏
页码:769 / 774
页数:6
相关论文
共 20 条
[1]   Treatment of Clostridium difficile-associated disease:: old therapies and new strategies [J].
Aslam, S ;
Hamill, R ;
Musher, DM .
LANCET INFECTIOUS DISEASES, 2005, 5 (09) :549-557
[2]  
BOLTON RP, 1984, ARCH DIS CHILD, V59, P466, DOI 10.1136/adc.59.5.466
[3]   Clinical manifestations, treatment and control of infections caused by Clostridium difficile [J].
Bouza, E ;
Muñoz, P ;
Alonso, R .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 :57-64
[4]  
BROOKS SE, 1992, INFECT CONT HOSP EP, V13, P98
[5]  
Clabots R, 1992, J INFECT DIS, V166, P561
[6]  
ELMOHANDES AE, 1993, BIOL NEONATE, V63, P225
[7]   Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis [J].
Kato, H ;
Kita, H ;
Karasawa, T ;
Maegawa, T ;
Koino, Y ;
Takakuwa, H ;
Saikai, T ;
Kobayashi, K ;
Yamagishi, T ;
Nakamura, S .
JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (08) :720-727
[8]   Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea [J].
Kyne, L ;
Warny, M ;
Qamar, A ;
Kelly, CP .
LANCET, 2001, 357 (9251) :189-193
[9]  
LARSON HE, 1978, LANCET, V1, P1063
[10]   EPIDEMIOLOGY OF CLOSTRIDIUM-DIFFICILE IN INFANTS [J].
LARSON, HE ;
BARCLAY, FE ;
HONOUR, P ;
HILL, ID .
JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (06) :727-733